WHAT WE DO

HeartBeat.bio is a drug discovery company dedicated to developing a high-throughput human organoid screening platform for cardiac drug discovery. The technology platform is built on the worldwide first, self-organizing, highly scalable cardiac organoids (Cardioids) which uniquely recapitulate the physiology of human heart chambers and enable modeling of diseases such as drug-induced and genetic cardiomyopathies as well as myocardial infarction and fibrosis. The Cardioid-based screening platform will lead to more relevant drug candidates and thus significantly reduce time and cost of cardiac drug development.

our team

We are a bunch of scientists and industry experts with diverse backgrounds, different nationalities but a common goal!

Michael Krebs

Michael Krebs

Martina Cirigliano

Martina Cirigliano

Pablo Hofbauer

Pablo Hofbauer

Tamara Durovic

Tamara Durovic

Tobias Griessler

Tobias Griessler

Francesca Murganti

Francesca Murganti

Lokesh Pimpale

Lokesh Pimpale

Rebecca Krasnik

Rebecca Kresnik

Florian Fuchs

Florian Fuchs

Laurenz Krebs

Laurenz Krebs

Pia Hager

Pia Hager

Emili Arasaverge

Emili Arasa Verge

funding partners

red-stars.com data AG is an operative holding company engaged in the global penetration of highly scalable innovative technologies, utilizing and commercializing scientific IP and software.

Cooperation partners